Overview
- New technologies and their applications in tumor diagnosis, treatment, and prognosis are discussed
- Methods to assess the effectiveness of cancer treatments are presented
- The importance of the quality of life after cancer therapy is pointed out
- Molecular profiling of brain tumors to select targeted therapy in clinical trials is explained
- A large number of color figures are included
Part of the book series: Tumors of the Central Nervous System (TCNS, volume 8)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (33 chapters)
-
Medulloblastoma
-
Retinoblastoma
Keywords
About this book
Reviews
From the reviews:
“This volume in the series, Tumors of the Central Nervous System, explores recent developments in tumor biology and newer classification and treatment information for seven distinct types of brain tumors. … The book is written for oncologists, both fellows and practitioners, neuro-oncologists, neurologists, neuropathologists, and neurosurgeons. … In addition to providing an update, the book can also inspire a new generation of researchers in tumor biology and in the design of more effective and scientifically based chemotherapy.” (Ramsis Farid Ghaly, Doody’s Review Service, October, 2012)Editors and Affiliations
Bibliographic Information
Book Title: Tumors of the Central Nervous System, Volume 8
Book Subtitle: Astrocytoma, Medulloblastoma, Retinoblastoma, Chordoma, Craniopharyngioma, Oligodendroglioma, and Ependymoma
Editors: M.A. Hayat
Series Title: Tumors of the Central Nervous System
DOI: https://doi.org/10.1007/978-94-007-4213-0
Publisher: Springer Dordrecht
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Science+Business Media B.V. 2012
Hardcover ISBN: 978-94-007-4212-3Published: 07 June 2012
Softcover ISBN: 978-94-024-0601-6Published: 23 August 2016
eBook ISBN: 978-94-007-4213-0Published: 14 June 2012
Series ISSN: 2215-096X
Series E-ISSN: 2215-0978
Edition Number: 1
Number of Pages: XXXVII, 347
Topics: Cancer Research, Oncology, Pathology, Neurosciences, Primary Care Medicine